MedPath

Peroperative Administration of Tranexamic Acid in Sleeve gastrectomy (PATAS) to reduce hemorrhage rates

Phase 3
Completed
Conditions
10003018
hemorrhage
Sleeve gastrectomy
10064477
10017998
Registration Number
NL-OMON47960
Lead Sponsor
Sint Franciscus Gasthuis
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
112
Inclusion Criteria

Primary laparoscopic sleeve gastrectomy; good command of the Dutch or English
language

Exclusion Criteria

Patients unwilling to give informed consent, patients with a medical history of
bleeding or VTE and patients who use therapeutic anticoagulants. Patients will
also be excluded in case of peroperative arterial bleeding or (iatrogenic)
bleeding coming from surrounding organs or vascular structures

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Primary outcome measures are peroperative use of hemostatic clips, the decrease<br /><br>in hemoglobin after the procedure and rates of postoperative hemorrhage (i.e.<br /><br>hemorrhage needing administration of packed cells or a surgical or radiological<br /><br>re-intervention). </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Secondary outcome measures are rates of deep venous thrombosis (DVT) and<br /><br>pulmonary embolism (PE). </p><br>
© Copyright 2025. All Rights Reserved by MedPath